Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Extension Study Examining the Safety and Tolerability of Memantine in Patients With Moderate to Severe Dementia of the Alzheimer's Type Having Completed Study 10158

NCT00857233 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT00857233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00857233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Extension Study Examining the Safety and Tolerability of Memantine in Patients With Moderate to Severe Dementia of the Alzheimer's Type Having Completed Study 10158
Lead sponsor
H. Lundbeck A/S
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2004
Completion date
October 31, 2010
Enrollment
297 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease